相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。V-ATPase is a candidate therapeutic target for Ewing sarcoma
Sofia Avnet et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma
Hege O. Ohnstad et al.
CANCER (2013)
Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells
Murielle Mimeault et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects
M. A. Pierotti et al.
ONCOGENE (2013)
Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors
Aung Naing et al.
CLINICAL CANCER RESEARCH (2012)
Insulin resistance and cancer: epidemiological evidence
Manami Inoue et al.
ENDOCRINE-RELATED CANCER (2012)
Metformin Inhibits Growth of Thyroid Carcinoma Cells, Suppresses Self-Renewal of Derived Cancer Stem Cells, and Potentiates the Effect of Chemotherapeutic Agents
Guofang Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Metformin in cancer: translational challenges
Ryan J. O. Dowling et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
Identification of Common and Distinctive Mechanisms of Resistance to Different Anti-IGF-IR Agents in Ewing's Sarcoma
Cecilia Garofalo et al.
MOLECULAR ENDOCRINOLOGY (2012)
Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies
Suman Malempati et al.
PEDIATRIC BLOOD & CANCER (2012)
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Michael N. Pollak
CANCER DISCOVERY (2012)
Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer
Victoria Forte et al.
CARDIORENAL MEDICINE (2012)
Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy
Benedicte F. Jordan et al.
FRONTIERS IN PHARMACOLOGY (2012)
Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation
Hyung Gyun Kim et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
Isaam Ben Sahra et al.
CANCER RESEARCH (2011)
Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
Dimitrios Iliopoulos et al.
CANCER RESEARCH (2011)
Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
Guilherme Z. Rocha et al.
CLINICAL CANCER RESEARCH (2011)
Metformin protects against doxorubicin-induced cardiotoxicity: Involvement of the adiponectin cardiac system
Mari C. Asensio-Lopez et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
AMP-activated protein kinase-an energy sensor that regulates all aspects of cell function
D. Grahame Hardie
GENES & DEVELOPMENT (2011)
R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study
Alberto S. Pappo et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo
C. Algire et al.
ONCOGENE (2011)
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling
C. Garofalo et al.
ONCOGENE (2011)
Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures
Vivek Subbiah et al.
PLOS ONE (2011)
Heterogeneous Role of the Glutathione Antioxidant System in Modulating the Response of ESFT to Fenretinide in Normoxia and Hypoxia
Tapiwanashe Magwere et al.
PLOS ONE (2011)
Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor
Helen J. Knowles et al.
BMC CANCER (2010)
Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells
Mahvash Zakikhani et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Synthetic Lethality Screens Reveal RPS6 and MST1R as Modifiers of Insulin-like Growth Factor-1 Receptor Inhibitor Activity in Childhood Sarcomas
Jenny C. Potratz et al.
CANCER RESEARCH (2010)
Hypoxia Modulates EWS-FLI1 Transcriptional Signature and Enhances the Malignant Properties of Ewing's Sarcoma Cells In vitro
Dave N. T. Aryee et al.
CANCER RESEARCH (2010)
NVP-BEZ235 as a New Therapeutic Option for Sarcomas
Maria C. Manara et al.
CLINICAL CANCER RESEARCH (2010)
Crosstalk between Insulin/Insulin-like Growth Factor-1 Receptors and G Protein-Coupled Receptor Signaling Systems: A Novel Target for the Antidiabetic Drug Metformin in Pancreatic Cancer
Enrique Rozengurt et al.
CLINICAL CANCER RESEARCH (2010)
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer et al.
DIABETES CARE (2010)
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab(CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
David Olmos et al.
LANCET ONCOLOGY (2010)
Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?
Vuk Stambolic et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study
Jonathan L. Wright et al.
CANCER CAUSES & CONTROL (2009)
The Insulin-like Growth Factor-1 Receptor-Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma
Raushan T. Kurmasheva et al.
CANCER RESEARCH (2009)
Insulin Receptor Isoform A and Insulin-like Growth Factor II as Additional Treatment Targets in Human Osteosarcoma
Sofia Avnet et al.
CANCER RESEARCH (2009)
Molecular genetics of sarcomas: Applications to diagnoses and therapy
Junya Toguchida et al.
CANCER SCIENCE (2009)
Genome-wide inhibitory impact of the AMPK activator metformin on [kinesins, tubulins, histones, auroras and polo-like kinases] M-phase cell cycle genes in human breast cancer cells
Cristina Oliveras-Ferraros et al.
CELL CYCLE (2009)
mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (TykerbA®)
Alejandro Vazquez-Martin et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
Antonino Belfiore et al.
ENDOCRINE REVIEWS (2009)
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Donghui Li et al.
GASTROENTEROLOGY (2009)
Metformin in Breast Cancer: Time for Action
Pamela J. Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Targeting insulin-like growth factor 1 receptor in sarcomas
Katia Scotlandi et al.
CURRENT OPINION IN ONCOLOGY (2008)
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Monica Buzzai et al.
CANCER RESEARCH (2007)
HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells
Ryo Fukuda et al.
CELL (2007)
Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance
M. Kilic et al.
ONCOGENE (2007)
The role of the IGF system in cancer growth and metastasis: Overview and recent insights
Amir Abbas Samani et al.
ENDOCRINE REVIEWS (2007)
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors
K Scotlandi et al.
CANCER RESEARCH (2005)
Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo
A Sullivan et al.
ONCOGENE (2004)
Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities
M Serra et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A
L Sciacca et al.
ONCOGENE (2002)
分享论文
